Hiroshi Yoshida

59PUBLICATIONS
126CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)MechanobiologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Sep 17, 2026
Prognostic Impact of Serum microRNA Profiles on the Progression-Free Survival of Patients With High-Grade Serous Ovarian Cancer Receiving Neoadjuvant Chemotherapy.

|May 06, 2026
Illustrating the "Quiet Genome" Concept of SMARCA4 -Deficient Uterine Sarcoma Via Whole-Exome Sequencing: A Highly Aggressive Case in a Young Woman.

|Mar 30, 2026
Genomic and Transcriptomic Analysis of High-Grade Endometrial Carcinoma Reveals Biological Heterogeneity and Molecular Classification Challenges.

Masahito Kawazu, Ayumi Taguchi, Emiko Yoshida

|Feb 26, 2026
Gastric-Type Cervical Adenocarcinoma: Clinicopathologic Features, Molecular Landscape, and Therapeutic Challenges.

Hiroshi Yoshida, Daiki Higuchi, Waku Takigawa

|Feb 26, 2026
Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection.

Taro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi

|Jan 30, 2026
Epithelioid leiomyosarcoma harboring HMGA2::RAD51B fusion: expanding the spectrum of RAD51B-rearranged uterine sarcoma.

Hiroshi Yoshida, Yuki Kojima

Pageof 10

Frequent Collaborators

11 joint publications

Tomoyasu Kato

9 joint publications

Tadaaki Nishikawa

8 joint publications

Mayumi Kobayashi-Kato

8 joint publications

Kan Yonemori